Koye Pharmaceuticals Private Limited, a active private limited company, was established on 12 May 2013 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74120MH2013PTC243214. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹46.01 Cr and a paid-up capital of ₹21.58 Cr.
It upholds a compliant status. Employing 673 professional, Its leadership includes Ravindra Yogesh Shenoy (Director), Preetish Mohan Toraskar (Director), Vishal Kaushik (Additional Director). Past directors included Ravindra Yogesh Shenoy, Nikhil Tambolkar, Anjana Sasidharan. It holds ₹101.45 Cr open charges and ₹149.76 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sf A-01, Art Guild House, Phoenix Market City Annexe,, Lbs Marg, Kurla (West), Mumbai, Mumbai, Maharashtra, 400070.
U74120MH2013PTC243214
243214
12 May 2013
₹46.01 Cr
₹21.58 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Koye Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravindra Yogesh Shenoy | Director | 16 Jul 2013 | Current |
| Preetish Mohan Toraskar | Director | 09 Sep 2013 | Current |
| Vishal Kaushik | Additional Director | 27 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 31 Jul 2013 | Past |
| Pramod Abcsdd | Nominee Director | 30 Sep 2024 | Past |
| Pramod Abcsdd | Nominee Director | 23 Mar 2020 | Past |
| Pramod Abcsdd | Nominee Director | 11 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2014 | Past |
| Pramod Abcsdd | Nominee Director | 13 Oct 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Koye Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.81% decrease. The company also saw a substantial fall in profitability, with a 346.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 387.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Koye Pharmaceuticals had a promoter holding of 99.90% and a public holding of 0.10%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,014,500,000.00
₹1,497,605,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2023 | Others | ₹20.00 Cr | Open |
| 22 Mar 2022 | Others | ₹36.85 Cr | Open |
| 14 Jan 2022 | Tjsb Sahakari Bank Limited | ₹3.00 Cr | Open |
| 26 Oct 2021 | Axis Bank Limited | ₹15.00 Cr | Open |
| 18 May 2021 | Axis Bank Limited | ₹26.60 Cr | Open |
Explore comprehensive loan charge details -
Koye Pharmaceuticals has a workforce of 673 employees as of Jan 23, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Koye Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Koye Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Vishal Kaushik was appointed as a Additional Director was appointed as a Additional Director on 27 Aug 2025 & has been associated with this company since 4 months 18 days . was recorded as a recent event.
Progress on A charge registered on 22 Feb 2022 via Charge ID 100551519 with Yes Bank Limited was fully satisfied on 17 Apr 2025. was documented.
A charge registered on 25 Jun 2021 via Charge ID 100501394 with Yes Bank Limited was fully satisfied on 17 Apr 2025. was recorded as a recent event.
The activity Koye Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge registered on 17 Mar 2022 via Charge ID 100558857 with Others was fully satisfied on 02 Sep 2024. was recorded as a recent event.
The activity Koye Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Supply disruptions have also been witnessed with popular chewable vitamin C tablet, Limcee.Limcee Plus has vitamin C and amino acid and thus does not only target patients who suffer from vitamin C deficiency.
InnoVen Capital India aims to disburse about $60-65 million in venture debt in 2016.
The CIN of Koye Pharmaceuticals Private Limited is U74120MH2013PTC243214.
Koye Pharmaceuticals Private Limited is headquartered at Sf A-01, Art Guild House, Phoenix Market City Annexe,, Lbs Marg, Kurla (West), Mumbai, Mumbai, Maharashtra, 400070.
Koye Pharmaceuticals Private Limited was incorporated on 12 May 2013.
The current directors of Koye Pharmaceuticals Private Limited are
The primary industry of Koye Pharmaceuticals Private Limited is Manufacturing.
Koye Pharmaceuticals Private Limited is unlisted.
The authorized capital of Koye Pharmaceuticals Private Limited is ₹46.01 Cr, and the paid-up capital is ₹21.58 Cr.
The compliance status of Koye Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX